Elsevier

Psychiatry Research

Volume 250, April 2017, Pages 169-176
Psychiatry Research

Comparison of psychopathological dimensions between major depressive disorder and schizophrenia spectrum disorders focusing on language, affectivity and motor behavior

https://doi.org/10.1016/j.psychres.2017.01.084Get rights and content

Highlights

  • Assessment of psychosis symptom dimensions in schizophrenia and major depression.

  • increased negative affect ratings in MDD, but similar language and motor behavior.

  • extreme ratings of motor and language dimensions more common among schizophrenia.

  • psychosis dimensions support transdiagnostic assessment in MDD and schizophrenia.

Abstract

This study tested whether patients with major depressive disorder (MDD) and schizophrenia spectrum disorders would differ in three dimensions of psychopathology (language, affectivity and motor behavior) as assessed by the Bern Psychopathology Scale (BPS) in a cohort of 58 patients with MDD and 146 patients with schizophrenia spectrum disorders. The overall estimation of severity of each of the three dimensions was rated on a seven-point Likert scale from severely inhibited to severely disinhibited. Here, more than half of the patients endorsed ratings that showed normal or mildly (dis-)inhibited behavior. At group level more pronounced negative ratings of affect were seen in MDD. Group comparisons of the severity ratings on language or motor behavior yielded no differences between schizophrenia spectrum disorders and MDD. At the individuals’ levels, extreme ratings in the language and motor dimensions were more frequent in schizophrenia spectrum disorders and in the affectivity dimension more frequent in MDD. Shared psychopathological features could be seen across diagnoses, supporting a dimensional approach to psychopathology in endogenous psychoses. However, the groups differ in the severity of affect ratings as well as in the distribution of language, affectivity and motor ratings with more variance among the group of schizophrenia spectrum disorders.

Introduction

Schizophrenia is a severe mental illness affecting about one percent of the adult population in the US and worldwide (Regier et al., 1993). It has been hypothesized that the psychopathological symptoms of psychosis are strongly related to functional and structural abnormalities in brain circuitry (Heckers, 2015). Theoretical models suggest an imbalance in brain regions of functions such as language, affectivity or motor behavior (Fujiwara et al., 2007, Hubl et al., 2004, Walther et al., 2009a, Walther et al., 2009b). Still, the neurobiology of schizophrenia is widely unknown. One of the problems hindering progress in schizophrenia research is the fact that past psychopathological dimensions map only poorly on brain circuits (Heckers, 2011). In order to assess clinical symptoms of psychosis and categorize specific subgroups with behavioral alterations in the three dimensions of language, affectivity, and motor behavior, the Bern Psychopathology Scale (BPS) was established (Strik et al., 2010). Indeed, dysfunction in the language, affect and motor system has been reported in schizophrenia in the past. Alterations in brain structure and function within the language system (i.e. superior temporal lobe and the arcuate fasciculus) have been linked to auditory verbal hallucinations and formal thought disorder in schizophrenia patients (Horn et al., 2009, Hubl et al., 2004, Strik et al., 2008, van de Ven et al., 2005). In addition, alterations in the affect dimension have been described: paranoid anxiety and delusions were related to abnormalities in the limbic system (i.e. within the ventral striatum, the amygdala and connecting fibers) (Bracht et al., 2014a, Juckel et al., 2006, Naidu et al., 2014, Romaniuk et al., 2010, Stegmayer et al., 2014b). Finally, aberrant motor behavior has been repeatedly observed in schizophrenia (Koning et al., 2010, Northoff, 2002, Peralta et al., 2010, Walther and Strik, 2012, Whitty et al., 2009). Some of these motor abnormalities were linked to alterations in the motor system (i.e. within the supplementary motor area, the basal ganglia and connecting fibers) (Bracht et al., 2013, Dazzan et al., 2004, Scheuerecker et al., 2009, Stegmayer et al., 2014a, Thomann et al., 2009, Walther, 2015, Walther et al., 2011a, Walther et al., 2016). However, previous findings have been inconsistent or incomplete as most symptom driven studies focused only on one sign or one dimension of psychopathology. Thus, a neurobiologically informed phenomenology should take the three system-specific psychosis dimensions into account.

Growing evidence suggests that schizophrenia and MDD share common pathophysiological features (Karpov et al., 2016, Klaassen et al., 2013, Owoeye et al., 2013, Schrijvers et al., 2008, Walther and Strik, 2012). Not only has depression been frequently observed in patients with schizophrenia, but unipolar depression may be accompanied by psychotic symptoms. Furthermore, MDD is similar to schizophrenia in clinical and neuropsychological characteristics, e.g. negative symptoms and anergic state (Rosen et al., 2012). Particularly patients with psychotic depression present similar ratings in the assessment of negative symptoms, neurological soft signs, motor abnormalities, executive functioning and quality of life (Hill et al., 2004, Owoeye et al., 2013). Therefore, MDD and schizophrenia spectrum disorders may share more features than previously assumed. Still, there are major differences between schizophrenia and MDD, such as diverging scores in positive symptoms, formal thought disorder (Kircher et al., 2014) and paranoid delusions (Rosen et al., 2012). Focusing on the three brain systems of interest, evidence suggests that MDD patients suffer from thought disorder such as rumination (Kuhn et al., 2012), affective dysregulation involving the limbic system (Graham et al., 2013), and may also experience psychomotor disturbances (agitation or retardation)(Schrijvers et al., 2008; Walther et al., 2012a). Moreover there is a substantial heterogeneity in symptom presentation in both disorders. Nonetheless, previous research suggests greater symptom heterogeneity in schizophrenia patients compared to patients with major depression, though there has been some inconsistency (Rink et al., 2016). However, the association of the three system-specific dimensions in MDD has not been investigated so far. Neither have these dimensions been compared between MDD and schizophrenia spectrum disorders.

We therefore aimed to assess global scores for each of the three symptom dimensions language, affectivity and motor behavior in schizophrenia as indicated by the BPS, comparing our findings to a cohort of patients suffering from major depression disorder. Our research focused on investigating the relationship between those two disorders, for phenomenological similarities can be observed in the clinical setting, as mentioned above. We hypothesized that both clinical groups would demonstrate alterations in all three dimensions, but that schizophrenia patients present alterations in the language and motor system more frequently than patients with MDD.

Section snippets

Subjects

This study was conducted at the University Hospital of Psychiatry Bern, Switzerland and included a large sample of 146 patients with schizophrenia spectrum disorders without any prodromal states (77 men, 69 women) and a sample of 58 patients with major depressive disorder (31 men, 27 women). Diagnoses were given by board-certified psychiatrists according to DSM-IV criteria based on clinical interviews and thorough review of all available case files. Patients were classified by their lifetime

Demographic and clinical parameters

In the analysis of patient characteristics, patients with schizophrenia spectrum disorders were younger and had longer duration of illness than MDD patients (see Table 1, age: F=12.9, d.f.=1, 202, p<0.001; duration of illness: F=9.3, d.f.=1, 202, p=0.003). Within MDD patients we noted positive correlations between HAMD and PANSS-P (r=0.44, p=0.001) and PANSS-N (r=0.50, p<0.001). Likewise, positive correlations between depression and psychosis measures emerged within the patients with

Discussion

The present study aimed to test whether patients with major depressive disorder and schizophrenia spectrum disorders would differ in three dimensions of psychopathology as assessed by the Bern Psychopathology Scale (BPS). This investigation represents the first application of BPS in a combined cohort of patients with MDD and schizophrenia spectrum disorders. We compared the two diagnostic entities in terms of severity and endorsement of the three BPS dimensions language, affectivity and motor

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Conflict of interest

S. Walther has received speaker's fees from Eli Lilly, Janssen-Cilag and Sandoz and was advisory board member to Lundbeck and Otsuka. F. U. Lang has received financial support and remunerations for congresses from AstraZeneca, Janssen-Cilag, and Lundbeck. M. Jäger has received remunerations and financial support for congresses from AstraZeneca, Eli Lilly, und Janssen-Cilag. All other authors report no conflicts of interest.

Acknowledgments

None.

References (63)

  • M. Kinou et al.

    Differential spatiotemporal characteristics of the prefrontal hemodynamic response and their association with functional impairment in schizophrenia and major depression

    Schizophr. Res.

    (2013)
  • T. Kircher et al.

    A rating scale for the assessment of objective and subjective formal thought and language disorder (TALD)

    Schizophr. Res.

    (2014)
  • S. Kuhn et al.

    Why ruminators won't stop: the structural and resting state correlates of rumination and its relation to depression

    J. Affect Disord.

    (2012)
  • F.U. Lang et al.

    Factor structure of the Bern Psychopathology Scale in a sample of patients with schizophrenia spectrum disorders

    Eur. Psychiatry

    (2015)
  • F.U. Lang et al.

    Subtyping schizophrenia: a comparison of positive/negative and system-specific approaches

    Compr. Psychiatry

    (2015)
  • F.U. Lang et al.

    Dimensional approaches to schizophrenia: a comparison of the Bern Psychopathology scale and the five-factor model of the Positive and Negative Syndrome scale

    Psychiatry Res.

    (2016)
  • J.W. Murrough et al.

    Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies

    Neurobiol. Learn Mem.

    (2011)
  • L. Rink et al.

    Characteristics and heterogeneity of schizoaffective disorder compared with unipolar depression and schizophrenia - a systematic literature review and meta-analysis

    J. Affect Disord.

    (2016)
  • J. Scheuerecker et al.

    Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI

    J. Psychiatr. Res.

    (2009)
  • G. Schoretsanitis et al.

    Keep at bay! - Abnormal personal space regulation as marker of paranoia in schizophrenia

    Eur. Psychiatry

    (2016)
  • D. Schrijvers et al.

    Psychomotor symptoms in depression: a diagnostic, pathophysiological and therapeutic tool

    J. Affect Disord.

    (2008)
  • K. Stegmayer et al.

    Supplementary motor area (SMA) volume is associated with psychotic aberrant motor behaviour of patients with schizophrenia

    Psychiatry Res.

    (2014)
  • K. Stegmayer et al.

    Ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation

    Neuroimage Clin.

    (2014)
  • V.G. van de Ven et al.

    The spatiotemporal pattern of auditory cortical responses during verbal hallucinations

    Neuroimage

    (2005)
  • S. Walther

    Psychomotor symptoms of schizophrenia map on the cerebral motor circuit

    Psychiatry Res.-Neuroimaging

    (2015)
  • S. Walther et al.

    Objectively measured motor activity in schizophrenia challenges the validity of expert ratings

    Psychiatry Res.

    (2009)
  • S. Walther et al.

    Alterations of white matter integrity related to motor activity in schizophrenia

    Neurobiol. Dis.

    (2011)
  • S. Walther et al.

    Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia

    Psychiatry Res.

    (2011)
  • S. Walther et al.

    Neural correlates of disbalanced motor control in major depression

    J. Affect Disord.

    (2012)
  • S. Walther et al.

    Frontal white matter integrity is related to psychomotor retardation in major depression

    Neurobiol. Dis.

    (2012)
  • A. Barth et al.

    [Development of a proverb test for assessment of concrete thinking problems in schizophrenic patients]

    Nervenarzt

    (2001)
  • Cited by (10)

    • Hand gesture performance is impaired in major depressive disorder: A matter of working memory performance?

      2021, Journal of Affective Disorders
      Citation Excerpt :

      Neuroimaging studies have also shown that poor gesture performance is directly related with reduced structural connectivity and cortical thickness, as well as, hypoactivation and altered resting-state functional connectivity within the left frontal-parietal-temporal network in patients with schizophrenia (Stegmayer et al., 2016a;Stegmayer et al., 2018;Viher et al., 2018;Wuthrich et al., 2020). Schizophrenia and depression share some core phenotyping similarities in the affective domain (Annen et al., 2012;Olsen et al., 2015;Steinau et al., 2017) and both may present a generalized slowing of physical activity known as psychomotor retardation, which affects fine and gross motor behavior, as well as, motor speed and velocity, facial expressions and speech production (Nelson and Charney, 1981;Hoffmann et al., 1985;Lemke et al., 1997;Lemke et al., 2000;Morrens et al., 2007;Bennabi et al., 2013;Walther et al., 2019). Although psychomotor retardation has long been associated with severity of depressive symptoms, the performance of hand gestures has been greatly overlooked in depression.

    • Blinded Clinical Ratings of Social Media Data are Correlated with In-Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls

      2020, Psychiatry Research
      Citation Excerpt :

      Rude and colleagues (Rude, Gortner et al. 2004) found in a text analysis program that the incidence of negatively valence words and use of the pronoun I were used more often in those with current major depressive disorder compared to healthy controls. Thus, in both people with schizophrenia and major depressive disorder, these disorders appear to possess some shared psychopathological language features across diagnoses that could be used as a biomarker or to help predict the underlying disorder or illness severity (Steinau, Stegmayer et al. 2017, Merchant, Asch et al. 2019). Social media provide a significant opportunity for access to patient language, since they are the locus for a large and growing proportion of everyday language use and communication.

    • Increased structural connectivity of the medial forebrain bundle in schizophrenia spectrum disorders is associated with delusions of paranoid threat and grandiosity

      2019, NeuroImage: Clinical
      Citation Excerpt :

      For example, the presence of few but severe affective signs (e.g. an isolated but severe paranoid threat of poisoning) would still result in a high global severity score of the affectivity domain. Internal consistency and external validity of the BPS has been demonstrated repeatedly (Bracht et al., 2012; Lang et al., 2016, 2015a, 2015b; Schoretsanitis et al., 2016; Stegmayer et al., 2014b, 2017; Steinau et al., 2017; Strik et al., 2010). SSD-patients were grouped into clinically homogeneous subgroups according to the severity of psychotic affectivity based on the BPS affectivity domain global score.

    • Specific cerebral perfusion patterns in three schizophrenia symptom dimensions

      2017, Schizophrenia Research
      Citation Excerpt :

      The BPS comprises no sum score or global score across the three dimensions; detailed information is given in the original publication (Strik et al., 2010). Good internal consistency and external validity of the BPS has been shown (Bracht et al., 2012; Lang et al., 2016; Lang et al., 2015a; Lang et al., 2015b; Schoretsanitis et al., 2016; Stegmayer et al., 2014a, b; Steinau et al., 2017; Strik et al., 2010). In line with previous studies (Lang et al., 2015b; Stegmayer et al., 2014a, b) we chose a prototypical approach to data analysis: we defined three patient subgroups according to the severity of alteration (severe, mild and no alteration) for each dimension, regardless of the direction (+ or −) on the global rating.

    View all citing articles on Scopus
    View full text